Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Abbisko Therapeutics Obtains Approval from The China NMPA to Conduct a Phase II Clinical Study of Pimicotinib (ABSK021) in cGVHD 2023-01-18 07:00
CGTN: China's COVID-19 vaccines proven safe, effective by trials and data 2023-01-17 23:50
NOVARAD PROVIDES FREE DIGITAL HEALTH RECORD SHARING TECHNOLOGY TO HOSPITALS IN DEVELOPING COUNTRIES 2023-01-17 22:15
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management 2023-01-17 22:00
Health in Transportation, NuraLogix Release New Smartphone Face-Scanning Application Aimed at Uncovering Life-Threatening Health Concerns in Professional Drivers 2023-01-17 22:00
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management 2023-01-17 20:41
Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World's Only Robotic Radiation Therapy Delivery Device 2023-01-17 20:35
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC 2023-01-17 19:42
OPHTECS Global Team Welcomes Dr. Schnider, One of Most Influential Women in Optical Industry and One of World's Most Prominent Contact Lens Researchers and Educators 2023-01-17 14:00
Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere 2023-01-17 08:29
Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery 2023-01-17 08:00
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China 2023-01-17 08:00
Fiberstar, Inc. Launches New Organic Citrus Fibers for Food & Beverages 2023-01-16 22:05
ESAOTE S.p.A. gets on board with "The Ocean Race: Genova, the Grand Finale". 2023-01-16 20:00
Identity for All Children and their Brighter Future in an Accessible Society for All 2023-01-16 16:12
MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe 2023-01-16 12:00
Ascletis Announces Dosing of 4 Healthy Subjects of the First Cohort in Multiple-Dose Escalation Phase I Clinical Trial of Oral 3CLpro Inhibitor ASC11 for COVID-19 2023-01-16 08:10
Forever Living Products International Announces New President 2023-01-16 08:05
CGTN: China protects lives, shares experience in global COVID-19 fight 2023-01-16 07:29
Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board 2023-01-14 22:00
1 130 131 132 133 134 742